Explaining Immunotherapy Pd L1 And Pd 1

Dr. Edward Garon explains the role of immunotherapy, PD-L1 and PD-1 in lung cancer. For more information visit lung.org/immunotherapy.

Support for this educational program provided by Amgen, AstraZeneca, Blueprint Medicines, Bristol Myers Squibb, Genentech, Lilly Oncology, Merck, Novartis and Pfizer.

  • Explaining Immunotherapy, PD-L1 and PD-1 ( Download)
  • Cancer Immunotherapy - PD-1 and PD-L1 ( Download)
  • PD-L1/PD-1 Pathway: A Security Checkpoint ( Download)
  • Cancer immunotherapy | The PD-L1 pathway ( Download)
  • Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers ( Download)
  • Dr. Brahmer Explains PD-1 and PD-L1 ( Download)
  • Car brakes: PD-1/PD-L1 molecular pathway explained ( Download)
  • Targeted Therapies: The Future of Non-small cell lung cancer (NSCLC) Treatment ( Download)
  • PD-1 Immunotherapy explained in under 2 minutes! ( Download)
  • Immunotherapy: Moving beyond PD1 and PDL1 inhibitors ( Download)
  • How does PD-L1 impact treatment options for lung cancer ( Download)
  • Immunotherapy - PD-1 and Beyond - Melanoma Education Symposium, Patrick Ott MD PhD ( Download)
  • Targeting PD-1 and PD-L1 for lung cancer therapy ( Download)
  • Dr. Brahmer on the Role of PD-1 and PD-L1 ( Download)
  • Immunotherapy/Checkpoint Inhibitor, Targeted Immunotherapy Drugs 5/2/18 ( Download)

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com